We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-12.77%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$44.2B
AUM Growth
-$8.44B
(-16%)
Cap. Flow
-$301M
Cap. Flow
% of AUM
-0.68%
Top 10 Holdings %
Top 10 Hldgs %
14.01%
Holding
2,360
New
150
Increased
1,005
Reduced
998
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$209M |
| 2 |
CVS Health
CVS
|
+$195M |
| 3 |
Tyson Foods
TSN
|
+$136M |
| 4 |
ExxonMobil
XOM
|
+$135M |
| 5 |
LyondellBasell Industries
LYB
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$239M |
| 2 |
Microsoft
MSFT
|
+$204M |
| 3 |
Johnson & Johnson
JNJ
|
+$157M |
| 4 |
Amazon
AMZN
|
+$144M |
| 5 |
Walmart Inc
WMT
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.23% |
| 2 | Healthcare | 16.49% |
| 3 | Financials | 11.74% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
THS
1976
DELISTED
Treehouse Foods
THS
| $216K | ﹤0.01% |
5,272
-2,392
| -31% | -$87.8K |
|
1977
German American Bancorp
GABC
$1.87B
| $215K | ﹤0.01% |
6,286
-4,671
| -43% | -$169K |
|
1978
Vitamin Cottage Natural Grocers
NGVC
$605M
| $215K | ﹤0.01% |
+13,462
| New | +$250K |
|
1979
Alarm.com
ALRM
$2.79B
| $214K | ﹤0.01% |
3,466
-6,227
| -64% | -$383K |
|
1980
Comtech Telecommunications
CMTL
$51.5M
| $213K | ﹤0.01% |
+23,491
| New | +$293K |
|
|
CTO
1981
CTO Realty Growth
CTO
$805M
| $213K | ﹤0.01% |
10,452
-141
| -1% | -$2.96K |
|
1982
CryoPort
CYRX
$747M
| $210K | ﹤0.01% |
6,787
-1,117
| -14% | -$29.7K |
|
1983
Starwood Property Trust
STWD
$6.16B
| $210K | ﹤0.01% |
10,061
-17,271
| -63% | -$397K |
|
1984
Provident Financial Services
PFS
$3.17B
| $208K | ﹤0.01% |
9,364
-2,066
| -18% | -$46.2K |
|
1985
International Seaways
INSW
$4.48B
| $207K | ﹤0.01% |
+9,754
| New | +$214K |
|
1986
Nicolet Bankshares
NIC
$3.63B
| $207K | ﹤0.01% |
+2,865
| New | +$232K |
|
1987
Clear Channel Outdoor Holdings
CCO
$1.23B
| $206K | ﹤0.01% |
192,725
-142,393
| -42% | -$298K |
|
|
KRON
1988
DELISTED
Kronos Bio
KRON
| $206K | ﹤0.01% |
+56,714
| New | +$257K |
|
1989
Performance Food Group
PFGC
$17.9B
| $206K | ﹤0.01% |
4,558
-18,144
| -80% | -$838K |
|
1990
Middleby
MIDD
$5.89B
| $205K | ﹤0.01% |
1,674
-4,787
| -74% | -$691K |
|
1991
Personalis
PSNL
$1.55B
| $205K | ﹤0.01% |
+59,527
| New | +$303K |
|
|
TELL
1992
DELISTED
Tellurian Inc.
TELL
| $205K | ﹤0.01% |
68,768
+47,697
| +226% | +$220K |
|
1993
Mitek Systems
MITK
$837M
| $204K | ﹤0.01% |
22,038
+5,559
| +34% | +$59.2K |
|
1994
Northeast Bank
NBN
$1.14B
| $202K | ﹤0.01% |
+5,529
| New | +$200K |
|
1995
Boyd Gaming
BYD
$5.92B
| $201K | ﹤0.01% |
4,090
-248,041
| -98% | -$14.3M |
|
1996
Quad
QUAD
$507M
| $199K | ﹤0.01% |
+72,275
| New | +$350K |
|
|
REV
1997
DELISTED
Revlon, Inc.
REV
| $197K | ﹤0.01% |
36,368
+3,357
| +10% | +$18.4K |
|
1998
Full House Resorts
FLL
$90.5M
| $196K | ﹤0.01% |
32,305
-1,901
| -6% | -$14.7K |
|
1999
Kopin
KOPN
$780M
| $195K | ﹤0.01% |
174,013
+161,516
| +1,292% | +$242K |
|
|
AFIB
2000
DELISTED
Acutus Medical Inc
AFIB
| $195K | ﹤0.01% |
174,352
+155,883
| +844% | +$134K |
|
Similar funds
VGA
AQR Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, AQR Capital Management held 2,360 positions worth $44.2B, down 16% from $52.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AQR Capital Management's Q2 2022 filing shows 150 new, 1,005 increased, 998 reduced and 187 closed positions. Its largest new stake was Fluor: 339,891 shares worth $7.86M. The largest sale was Thermo Fisher Scientific, an estimated $239M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- AQR Capital Management's largest Q2 2022 buy was Fluor: 339,891 shares worth $7.86M.
- AQR Capital Management added most to Gilead Sciences in Q2 2022, an estimated $209M increase.
- AQR Capital Management's biggest Q2 2022 reduction was Thermo Fisher Scientific, cutting an estimated $239M.
- AQR Capital Management fully exited Roku in Q2 2022, selling an estimated $32.5M.
- AQR Capital Management's ten largest holdings make up 14% of its $44.2B portfolio in Q2 2022.
- AQR Capital Management opened 150 new positions and closed 187 in Q2 2022.
- AQR Capital Management's portfolio value fell 16% quarter-over-quarter to $44.2B.
Based on AQR Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.